UAE Bioinformatics market is projected to grow from $76.75 Mn in 2022 to $275.08 Mn by 2030, registering a CAGR of 1.30% during the forecast period of 2022-30. The main factors driving the growth are government initiatives, advances in technology, and an increasing demand for personalized medicine. The market is segmented by technology and by application. Some of the major players include G42 Healthcare (ARE), Neo-Science (ARE), Agilent Technologies, IBM Life Sciences, and QIAGEN.
UAE Bioinformatics market is projected to grow from $76.75 Mn in 2022 to $275.08 Mn by 2030, registering a CAGR of 1.30% during the forecast period of 2022-30. In 2019, national healthcare spending in the UAE as a percentage of GDP reached 4.28% from 4.15% in 2018. The UAE government has made it a top priority to build a top-notch healthcare infrastructure, and as a result, the industry has developed and grown tremendously over the past few years.
The study of biology and information technology are combined in the discipline of bioinformatics. Data generation, data warehousing, data mining, data management, and other techniques are used in bioinformatics. Bioinformatics software and tools are used as integrated solutions to provide statistical techniques and data processing algorithms for applications including next-generation sequencing, modeling of genomic and proteomic structure, and three-dimensional drug discovery. The bioinformatics market in the Middle-Eastern region is still in its nascent stages. However, UAE is one of the leading countries in the Middle-Eastern bioinformatics market.
Market Growth Drivers
The UAE government has been making investments in the creation of bioinformatics resources and infrastructure, such as the Dubai Genome Center and the Abu Dhabi Advanced Research Center (ADARC), a molecular diagnostics company. This government support, advances in technology and an increasing demand for personalized medicine are expected to drive the bioinformatics market in UAE.
The factors that are limiting the growth of the market are limited awareness about the potential benefits of bioinformatics and the shortage of skilled workforce in this field which makes it challenging for companies to adapt or implement new applications or technologies.
November 2022: The MOU between G42 Healthcare and Asa Ren aims to create and improve genomic sequencing, bioinformatics capabilities, and digital health solutions to support the Indonesian Government's National Genomics Initiatives and the digitization of the healthcare sector.
January 2023: The acquisition of Verogen by QIAGEN with $150 Mn was made to strengthen the company's position as a leader in the field of human identification and forensics, which is backed by process automation, genetic testing analysis, and sample preparation. Verogen and Illumina MiSeq FGx, NGS-based panels, and GEDmatch bioinformatics solutions would be supplied beginning in 2021, according to the deal.
In the United Arab Emirates (UAE), the regulatory environment for the bioinformatics industry is still comparatively new and developing. Controlling and authorizing medical devices is within the purview of the Ministry of Health and Prevention (MOHAP). In the emirate of Dubai, the Dubai Health Authority (DHA) is responsible for overseeing the regulation of healthcare technology, including bioinformatics. Additionally, the UAE offers a variety of free trade zones that provide enterprises with laxer restrictions and incentives, including Dubai Silicon Oasis and Abu Dhabi Global Market. Furthermore, the UAE has put in place laws governing data security and privacy, including the Federal Law No. 2 of 2019 on Data Protection and the Cybercrime Law, which can be applicable to bioinformatics businesses that deal with genetically personal data.
In UAE, reimbursement policies are set by individual insurance firms as well as government-funded healthcare providers. The cost of some genetic testing and other bioinformatics services is typically covered by these policies, but the precise tests and services that are covered, as well as the amount of the reimbursement, can change. The Ministry of Health and Prevention (MOHAP) in the UAE establishes the norm for medical operations, including the price of genetic tests. The MOHAP also controls medical procedure costs in the private sector; these costs require the Ministry of Health approval.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
188.8.131.52 Product Applications and Services
184.108.40.206 Recent Developments
220.127.116.11 Partnerships Ecosystem
18.104.22.168 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Technology (Revenue, USD Billion):
By Application (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses